Literature DB >> 21868451

The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells.

Joshua D Stender1, Fabio Stossi, Cory C Funk, Tze Howe Charn, Daniel H Barnett, Benita S Katzenellenbogen.   

Abstract

The estrogen receptor α (ERα) is a master regulator of gene expression and works along with cooperating transcription factors in mediating the actions of the hormone estradiol (E2) in ER-positive tissues and breast tumors. Here, we report that expression of paired-like homeodomain transcription factor (PITX1), a tumor suppressor and member of the homeobox family of transcription factors, is robustly up-regulated by E2 in several ERα-positive breast cancer cell lines via ERα-dependent interaction between the proximal promoter and an enhancer region 5' upstream of the PITX1 gene. Overexpression of PITX1 selectively inhibited the transcriptional activity of ERα and ERβ, while enhancing the activities of the glucocorticoid receptor and progesterone receptor. Reduction of PITX1 by small interfering RNA enhanced ERα-dependent transcriptional regulation of a subset of ERα target genes. The consensus PITX1 binding motif was found to be present in 28% of genome-wide ERα binding sites and was in close proximity to estrogen response elements in a subset of ERα binding sites, and E2 treatment enhanced PITX1 as well as ERα recruitment to these binding sites. These studies identify PITX1 as a new ERα transcriptional target that acts as a repressor to coordinate and fine tune target-specific, ERα-mediated transcriptional activity in human breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868451      PMCID: PMC3182422          DOI: 10.1210/me.2011-0102

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  43 in total

Review 1.  The multifaceted mechanisms of estradiol and estrogen receptor signaling.

Authors:  J M Hall; J F Couse; K S Korach
Journal:  J Biol Chem       Date:  2001-07-17       Impact factor: 5.157

2.  Biomedicine. Defining the "S" in SERMs.

Authors:  Benita S Katzenellenbogen; John A Katzenellenbogen
Journal:  Science       Date:  2002-03-29       Impact factor: 47.728

Review 3.  Diversity in the mechanisms of gene regulation by estrogen receptors.

Authors:  Rocio Sanchez; Denis Nguyen; Walter Rocha; John H White; Sylvie Mader
Journal:  Bioessays       Date:  2002-03       Impact factor: 4.345

Review 4.  Combinatorial control of gene expression by nuclear receptors and coregulators.

Authors:  Neil J McKenna; Bert W O'Malley
Journal:  Cell       Date:  2002-02-22       Impact factor: 41.582

5.  Gene expression analysis of prostate cancers.

Authors:  Jian-Hua Luo; Yan Ping Yu; Kathleen Cieply; Fan Lin; Petrina Deflavia; Rajiv Dhir; Sydney Finkelstein; George Michalopoulos; Michael Becich
Journal:  Mol Carcinog       Date:  2002-01       Impact factor: 4.784

6.  Expression profiling reveals hepsin overexpression in prostate cancer.

Authors:  J A Magee; T Araki; S Patil; T Ehrig; L True; P A Humphrey; W J Catalona; M A Watson; J Milbrandt
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

7.  Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

Authors:  Y Shang; X Hu; J DiRenzo; M A Lazar; M Brown
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

8.  Specific protein-protein interaction between basic helix-loop-helix transcription factors and homeoproteins of the Pitx family.

Authors:  G Poulin; M Lebel; M Chamberland; F W Paradis; J Drouin
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

9.  Multiple mechanisms for Pitx-1 transactivation of a luteinizing hormone beta subunit gene.

Authors:  Philippa Melamed; Mingshi Koh; Prema Preklathan; Ling Bei; Choy Hew
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

10.  Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs.

Authors:  Zeynep Madak-Erdogan; Mathieu Lupien; Fabio Stossi; Myles Brown; Benita S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2010-10-18       Impact factor: 4.272

View more
  12 in total

Review 1.  NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms.

Authors:  Jonna Frasor; Lamiaa El-Shennawy; Joshua D Stender; Irida Kastrati
Journal:  Mol Cell Endocrinol       Date:  2014-10-18       Impact factor: 4.102

2.  PITX1 is a novel predictor of the response to chemotherapy in head and neck squamous cell carcinoma.

Authors:  Masao Takenobu; Mitsuhiko Osaki; Kazunori Fujiwara; Takahiro Fukuhara; Hiroya Kitano; Hiroyuki Kugoh; Futoshi Okada
Journal:  Mol Clin Oncol       Date:  2016-04-28

3.  PITX1, a specificity determinant in the HIF-1α-mediated transcriptional response to hypoxia.

Authors:  Sharon Mudie; Daniel Bandarra; Michael Batie; John Biddlestone; Sonia Moniz; Brian Ortmann; Alena Shmakova; Sonia Rocha
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  The PITX gene family as potential biomarkers and therapeutic targets in lung adenocarcinoma.

Authors:  Chunyi Zhang; Xing Chen; Yefeng Chen; Miaoying Cao; Jixian Tang; Bo Zhong; Meng He
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

5.  Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer.

Authors:  Yichao Li; Sushil K Jaiswal; Rupleen Kaur; Dana Alsaadi; Xiaoyu Liang; Frank Drews; Julie A DeLoia; Thomas Krivak; Hanna M Petrykowska; Valer Gotea; Lonnie Welch; Laura Elnitski
Journal:  BMC Cancer       Date:  2021-07-03       Impact factor: 4.430

6.  Coactivators enable glucocorticoid receptor recruitment to fine-tune estrogen receptor transcriptional responses.

Authors:  Michael J Bolt; Fabio Stossi; Justin Y Newberg; Arturo Orjalo; Hans E Johansson; Michael A Mancini
Journal:  Nucleic Acids Res       Date:  2013-02-26       Impact factor: 16.971

7.  Exposure to ionizing radiation induced persistent gene expression changes in mouse mammary gland.

Authors:  Kamal Datta; Daniel R Hyduke; Shubhankar Suman; Bo-Hyun Moon; Michael D Johnson; Albert J Fornace
Journal:  Radiat Oncol       Date:  2012-12-05       Impact factor: 3.481

8.  PITX1 is a reliable biomarker for predicting prognosis in patients with oral epithelial dysplasia.

Authors:  Motoki Nakabayashi; Mitsuhiko Osaki; Isamu Kodani; Futoshi Okada; Kazuo Ryoke; Mitsuo Oshimura; Hisao Ito; Hiroyuki Kugoh
Journal:  Oncol Lett       Date:  2013-12-24       Impact factor: 2.967

9.  Abnormal PITX1 gene methylation in adolescent idiopathic scoliosis: a pilot study.

Authors:  Benlong Shi; Liang Xu; Saihu Mao; Leilei Xu; Zhen Liu; Xu Sun; Zezhang Zhu; Yong Qiu
Journal:  BMC Musculoskelet Disord       Date:  2018-05-09       Impact factor: 2.362

10.  Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer.

Authors:  Qiaoyun Wang; Shuai Zhao; Lei Gan; Zhixiang Zhuang
Journal:  Biosci Rep       Date:  2020-09-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.